These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16940434)

  • 1. Soluble guanylyl cyclase activation promotes angiogenesis.
    Pyriochou A; Beis D; Koika V; Potytarchou C; Papadimitriou E; Zhou Z; Papapetropoulos A
    J Pharmacol Exp Ther; 2006 Nov; 319(2):663-71. PubMed ID: 16940434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cGMP-dependent and -independent angiogenesis-related properties of nitric oxide.
    Pyriochou A; Vassilakopoulos T; Zhou Z; Papapetropoulos A
    Life Sci; 2007 Nov; 81(21-22):1549-54. PubMed ID: 17945311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway.
    Pyriochou A; Zhou Z; Koika V; Petrou C; Cordopatis P; Sessa WC; Papapetropoulos A
    J Cell Physiol; 2007 Apr; 211(1):197-204. PubMed ID: 17226792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump.
    Bawankule DU; Sathishkumar K; Sardar KK; Chanda D; Krishna AV; Prakash VR; Mishra SK
    J Pharmacol Exp Ther; 2005 Jul; 314(1):207-13. PubMed ID: 15792996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiogenesis by the poly(ADP-ribose) polymerase inhibitor PJ-34.
    Pyriochou A; Olah G; Deitch EA; Szabó C; Papapetropoulos A
    Int J Mol Med; 2008 Jul; 22(1):113-8. PubMed ID: 18575783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.
    Morbidelli L; Pyriochou A; Filippi S; Vasileiadis I; Roussos C; Zhou Z; Loutrari H; Waltenberger J; Stössel A; Giannis A; Ziche M; Papapetropoulos A
    Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R824-32. PubMed ID: 20032260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice.
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1093-102. PubMed ID: 17596536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B; Ni J; Vatish M; Singer DR
    Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
    Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
    Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase.
    Schindler U; Strobel H; Schönafinger K; Linz W; Löhn M; Martorana PA; Rütten H; Schindler PW; Busch AE; Sohn M; Töpfer A; Pistorius A; Jannek C; Mülsch A
    Mol Pharmacol; 2006 Apr; 69(4):1260-8. PubMed ID: 16332991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment.
    Ahluwalia A; Foster P; Scotland RS; McLean PG; Mathur A; Perretti M; Moncada S; Hobbs AJ
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1386-91. PubMed ID: 14742866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of ERK and Akt signaling in endothelial cell angiogenic responses to beta-amyloid.
    Magrane J; Christensen RA; Rosen KM; Veereshwarayya V; Querfurth HW
    Exp Cell Res; 2006 Apr; 312(7):996-1010. PubMed ID: 16427623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
    Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.
    Donnini S; Solito R; Giachetti A; Granger HJ; Ziche M; Morbidelli L
    J Pharmacol Exp Ther; 2006 Nov; 319(2):515-22. PubMed ID: 16868034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
    Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2.
    Kim SR; Bae SK; Choi KS; Park SY; Jun HO; Lee JY; Jang HO; Yun I; Yoon KH; Kim YJ; Yoo MA; Kim KW; Bae MK
    Biochem Biophys Res Commun; 2007 May; 357(1):150-6. PubMed ID: 17408594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo.
    Lam HW; Lin HC; Lao SC; Gao JL; Hong SJ; Leong CW; Yue PY; Kwan YW; Leung AY; Wang YT; Lee SM
    J Cell Biochem; 2008 Jan; 103(1):195-211. PubMed ID: 17497682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.